Abschluss eines nicht exklusiven Rabattvertrages nach§ 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Rasagilin (ATC-Code: N04BD02) innerhalb des Zeitraumes vom 01.10.2026 bis zum 30.09.2028 mit jederzeitiger Möglichkeit des Vertragsabschlusses während der Laufzeit („open-house-Modell“).

TENDER DESCRIPTION

For the active substance Rasagiline (ATC code: N04BD02), AOK Lower Saxony. The health insurance fund offers all interested pharmaceutical companies rebate contracts without selection decision for the period until the entry into force of exclusive contracts following a formal award procedure according to the regulations of Part 4 of the GWB. The contract conclusions take place within the framework of an "open-house model" and serve as a bridge between the start of generic competition (patent expiration) and the awarding of exclusive contracts. The offered contracts are non-exclusive; contracts with all market participants (pharmaceutical companies) are desired by AOK Lower Saxony. In the open-house model, uniform conditions apply to all participants. Contract contents, conditions and access procedures are uniform – individual negotiations are generally not conducted. Contract durations are a maximum of twenty-four months, the earliest contract start date is 01.10.2026. All contracts end at the latest on 30.09.2028, regardless of the date of the respective contract conclusion. Joining or concluding a contract can take place within the twenty-four-month period on the first day of…

TENDER BRIEF

TENDER DOCUMENTS